featured
Mortality Reduction Associated With β-Blockers in Chronic Heart Failure Is Greater in the Setting of Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes
Diabetes Care 2017 Oct 05;[EPub Ahead of Print], KK Witte, M Drozd, AMN Walker, PA Patel, JC Kearney, S Chapman, RJ Sapsford, J Gierula, MF Paton, J Lowry, MT Kearney, RM CubbonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.